Phlebitis clinical trials

The registry lists 45 studies for Phlebitis across more than 10 countries. 9 are recruiting or about to start. 31 of them are mainly about Phlebitis (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-22. Counting its 2 narrower conditions too, such as Thrombophlebitis: 63 studies, 10 open.

Get an email when these change. Save the Phlebitis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 27
Not yet recruiting: 5
Status unknown: 5
Recruiting: 4
Terminated: 2
Withdrawn: 1

Phase

Phase 3: 5
Phase 2: 3
Phase 4: 3
Phase 1: 1

Where

Turkey: 12
France: 4
Brazil: 4
United States: 4
Italy: 4
Spain: 3

Who runs them

Kutahya Health Sciences University (3) · Karamanoğlu Mehmetbey University (2) · Cukurova University (2) · Federal University of São Paulo (2) · University of Florence (2) · The University of Queensland (1) · T.C. ORDU ÜNİVERSİTESİ (1) · The Reading Hospital and Medical Center (1)

What is being tested here

Drugs under test in Phlebitis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Nitroglycerin	1	0	2
Aloe vera gel	1	0	1
Dalteparin	0	0	1
Amiodarone	0	1	1

Who these studies take

Of the 4 Phlebitis studies recruiting now, 3 (75%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (25%) take healthy volunteers.

Recruiting studies that take each age, of 4
Age	Women	Men
10	0 (0%)	0 (0%)
18	4 (100%)	4 (100%)
30	4 (100%)	4 (100%)
40	4 (100%)	4 (100%)
50	4 (100%)	4 (100%)
65	4 (100%)	4 (100%)
75	4 (100%)	4 (100%)
85	4 (100%)	4 (100%)

Across all 45 studies, recruiting or not: 22% stop at 75 or younger and 20% at 65; 13% take children; 0% are for women only and 0% for men only; 27% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Phlebitis studies take

Of 21 interventional studies with no phase under Phlebitis, half reached primary completion within 8 months of starting, counting those still running.

Start to primary completion	Every sponsor	Industry	Non-industry
Interventional, no phase	8 mo5–16 · 21 studies	—	—

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Newly registered1

AI Prediction of PIVC-Related PhlebitisOct 22, 2026NCT07889895

Studies

Recruiting first, then most recently updated. Showing 45 of 45. search them.